Healthcare -
Biotechnology - NASDAQ - US
$ 25.33
11 %
$ 33.6 M
Market Cap
-0.38
P/E
LYRA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LYRA - Lyra Therapeutics, Inc.
8.53 M
LAST VALUE
-70.23%
2 YEAR CAGR
137.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR